BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cardinal Health completes sale of Cordis business to Hellman & Friedman

"We appreciate H&F's partnership throughout the transaction, and we are excited about Cordis's future under H&F's ownership," said Mike Kaufma...

August 03, 2021 | News

$3.3 million to support Australians living with a rare disease

The Morrison Government is providing $3.3 million to support the approximate two million Australians living with a rare disease, providing them with suppor...

August 02, 2021 | News

Neukio Biotherapeutics completed its $40m Angel round financing

Neukio Biotherapeutics, a newly established company, recently announced the completion of its $40m Angel round of financing led by Lilly Asi...

July 30, 2021 | News

LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic

LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...

July 26, 2021 | News

Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%

Biocon Ltd , an innovation-led global biopharmaceuticals company, announced its consolidated financial results for the first quarter ended June ...

July 26, 2021 | News

MiRXES Secures US$77 Million To Accelerate Multi-Cancer Early Detection

MiRXES Pte Ltd, a biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests, announced today it has ...

July 12, 2021 | News

Sartorius provides preliminary first-half financial key figures

Sartorius announces today that it expects strong first–half performance and raises its forecast for the full year of 2021. For the first six months e...

July 06, 2021 | News

Parexel will be acquired for $8.5B by EQT and Goldman Sachs

Four years after a private equity acquisition took Parexel private, the contract research organization is being acquired by two private equity firms for $8...

July 05, 2021 | News

Australia's Qbiotics concludes successful $85 million capital raise

Capital raise nets $85 million from Existing Shareholders, Existing Institutional Investors, and cornerstone investor TDM Growth Partners. Fun...

June 28, 2021 | News

CARsgen Therapeutics officially listing on HKEX

CARsgen Therapeutics Holdings Limited (the "Company", stock code: 2171.HK) today announced that the Company's Shares have been traded on the Main Board of ...

June 19, 2021 | News

Danaher To Acquire Aldevron for a price of approximately $9.6 billion.

Founded in 1998 by Michael Chambers and John Ballantyne, Aldevron is headquartered in Fargo, North Dakota and employs approximatel...

June 17, 2021 | News

ENA Respiratory secured up to AU$32m investment to Advances COVID-19 Preventative Therapy

Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051 Company a...

June 16, 2021 | News

Synaptogenix Announces $12.5 Million Private Placement

Synaptogenix intends to use the net proceeds from the private placement to support the ongoing development of Bryostatin-1, which is currently in a Phase&n...

June 15, 2021 | News

Verona Pharma and Nuance Pharma to Commercialize Ensifentrine in Greater China

$40 million upfront including $25 million cash and $15 million in equity in Nuance Biotech (parent company) Up to $179 million in potential clinical, regul...

June 11, 2021 | News

Stay Connected